Present status and future prospects of allergen immunotherapy in allergic rhinitis of China.
10.3760/cma.j.cn115330-20210727-00487
- Author:
Hong Fei LOU
1
;
Luo ZHANG
2
Author Information
1. Department of Otorhinolaryngology Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing 100730, China Beijing Key Laboratory of Allergic Diseases, Beijing Institute of Otorhinolaryngology, Beijing 100005, China Research Unit of Diagnosis and Treatment of Chronic Nasal Diseases, Chinese Academy of Medical Sciences (Beijing TongRen Hospital, Capital Medical University), Beijing 100730, China.
2. Department of Otorhinolaryngology Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing 100730, China Beijing Key Laboratory of Allergic Diseases, Beijing Institute of Otorhinolaryngology, Beijing 100005, China Research Unit of Diagnosis and Treatment of Chronic Nasal Diseases, Chinese Academy of Medical Sciences (Beijing TongRen Hospital, Capital Medical University), Beijing 100730, China Department of Allergy, Beijing TongRen Hospital, Capital Medical University, Beijing 100730, China.
- Publication Type:Journal Article
- MeSH:
Allergens;
China;
Desensitization, Immunologic;
Humans;
Rhinitis, Allergic/therapy*
- From:
Chinese Journal of Otorhinolaryngology Head and Neck Surgery
2022;57(4):385-391
- CountryChina
- Language:Chinese
